BG
MBII

BlackRock Group’s Marrone Bio Innovations, Inc. MBII Stock Holding History

BlackRock Group’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-301
Closed -$5K – 2809
2013
Q3 		$5K Buy
+301
New +$4.23K ﹤0.01% 2871

Other funds holding MBII

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

BlackRock Group's MBII Position: Q4 2013 in Review

BlackRock Group sold out of Marrone Bio Innovations, Inc. (MBII) in Q4 2013, closing a stake of 301 shares — an estimated $5K sold.

BlackRock Group first reported a position in MBII in Q3 2013 and held it in 1 quarter. The position peaked at $5K in Q3 2013. 40 funds tracked by Wall St. Rank hold MBII as of Q4 2013.

  • BlackRock Group reported no remaining Marrone Bio Innovations, Inc. position as of Q4 2013 after selling out during the quarter.
  • BlackRock Group sold 301 Marrone Bio Innovations, Inc. shares in Q4 2013, an estimated $5K.
  • BlackRock Group first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 1 quarter.
  • BlackRock Group's Marrone Bio Innovations, Inc. position peaked at $5K in Q3 2013.
  • 40 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q4 2013.

Based on BlackRock Group's 13F filing for Q4 2013, filed 12 Feb 2014.